Underlying genetic influences may affect perinatal pain, depression, or both. We
investigated the role of 59 single-nucleotide polymorphisms on 20 quantitative
traits measured in perinatal women. Moreover, 183 pregnant women (28–37 weeks’
gestation) were prospectively genotyped for single-nucleotide polymorphisms with
known prior associations with either pain or depression in nonpregnant
populations. Prenatal saliva samples were collected. Phenotypic data were
gathered during prenatal, labor and delivery, and postpartum (six weeks and
three months) periods, capturing labor pain, Edinburgh Postnatal Depression
Score, and Brief Pain Inventories. Following quality control, genotypes were
used as predictors and phenotypes as dependent variables in multiple linear
regression analyses to detect associations. Three statistical models were
tested: additive allele effects, deviation from dominant allele effects, and the
joint test of both. rs4633 (a synonymous single-nucleotide polymorphism in
COMT) associated with “pain right now” scores at six weeks
postpartum. Single-nucleotide polymorphisms rs1135349 (a single-nucleotide
polymorphism within a small noncoding RNA that has many prior associations for
depression) and rs7548151 (intronic in ASTN1) were associated
with the maximum pain unpleasantness score experienced during labor (a measure
of the emotional valence of labor pain), controlling for the Holm–Bonferroni
family-wise error rate. Sensory dimensions of labor pain (i.e., pain intensity)
and postpartum depression scores were not associated with genotyped
single-nucleotide polymorphisms. Identifying genomic components of these
perinatal complex disorders may produce insights into relevant pathways or novel
treatment options.